Potential therapeutic target for improving long-term memory identified
January 27th, 2011 - 2:17 pm ICT by ANILondon, Jan 27 (ANI): Scientists have identified a therapy that may enhance memory and prevent the loss of long-term memory.
Led by Cristina Alberini, Professor of Neuroscience at Mount Sinai School of Medicine, the research team evaluated how a protein called insulin-like growth factor II (IGF-II), a gene expressed during brain development that declines with aging, impacts memory formation and retention.
IGF-II is enriched in the adult brain in several areas, including the hippocampus and cortex, which are known to be important for memory formation.
Researchers injected the hippocampus of rats with the protein and found that IGF-II significantly improved long-term memory.
The team also found that IGF-II levels increased after learning, and that when that increase was blocked long-lasting memories could not form.
“The implications of these data are far-reaching and give us new clues about how to investigate memory loss and forgetfulness in people with cognitive impairment, like those with Alzheimer’s disease, stroke, or dementia,” said Dr. Alberini.
Prior to this study, very little, if anything, was known about IGF-II in adult brain functions. The researchers tested the impact of injecting IGF-II into rats after “inhibitory avoidance learning,” in which the rats learn to avoid an unpleasant experience.
They found that compared to control groups, the rats injected with IGF-II had a much stronger memory retention. In addition, the rats maintained an elevated memory for several weeks, while the control group showed diminished memory over the same period of time.
In collaboration with Robert Blitzer, PhD, Associate Professor of Pharmacology and Systems Therapeutics and Psychiatry at Mount Sinai, the research team also evaluated the impact of IGF-II at the cellular level.
They found that IGF-II had an impact on long-term potentiation (LTP). LTP is a type of synaptic plasticity, or the change in strength of the points of contact between nerve cells, that is believed to be critical for long-term memory formation. Dr. Blitzer and his team found that IGF-II promoted stable LTP, strengthening signal transmission between nerve cells and maintaining it for a longer period of time.
“This study is the first step to understanding the benefits of IGF-II,” said Dr. Alberini. “We have identified some of the mechanisms associated with this effect and look forward to further studying them and exploring the clinical relevance of IGF-II.”
The research is published in the January 27th issue of Nature. (ANI)
- Brain chemical boosts memory, could treat Alzheimer's - Jan 27, 2011
- Scientists find protein that boosts memory, prevents forgetfulness - Feb 03, 2011
- Star-shaped brain cells 'essential for making long-term memories' - Mar 04, 2011
- Scientists find proteins that reverse learning problems in Down's mice - Feb 19, 2011
- New discovery may lead to advances in treating anxiety disorders - Jan 08, 2011
- Scientists peer into real time brain cell activity - May 31, 2011
- Jet lag clouds memory for a long time - Nov 25, 2010
- Brain replays control decision-making process, not long-term memories - Mar 12, 2010
- Brain molecules linked to long-term memories discovered - Mar 21, 2011
- Mechanism behind memory formation during sleep uncovered - Sep 16, 2009
- Nerve-cell transplants help recover lost ability to learn in brain-damaged rats - Dec 10, 2009
- Enzyme enhances, erases rat's long-term memories - Mar 06, 2011
- Benefits on exercise on brain unravelled - May 20, 2012
- Nicotine exposure in pregnancy 'puts offspring at learning disabilities risk' - Dec 04, 2010
- First drug to demonstrate therapeutic effect in a type of autism identified - May 21, 2010
Tags: adult brain, avoidance learning, brain development, brain functions, cellular level, cognitive impairment, hippocampus, insulin like growth factor, lasting memories, london jan, long term memory, memory formation, memory loss, memory retention, mount sinai school, mount sinai school of medicine, robert blitzer, term potentiation, therapeutic target, unpleasant experience